SOP Guide for Pharma

Ointments: SOP for Documentation of Stability Study Results – V 2.0

SOP for Documentation of Stability Study Results – V 2.0

Procedure for Documentation of Stability Study Results

Department Quality Control (QC)/Quality Assurance (QA)/Research & Development (R&D)
SOP No. SOP/Ointment/107
Supersedes V 1.0
Page No. Page X of Y
Issue Date [Insert Issue Date]
Effective Date [Insert Effective Date]
Review Date [Insert Review Date]

1. Purpose

The purpose of this Standard Operating Procedure (SOP) is to define the process for documenting stability study results for ointments. This ensures that stability data is recorded systematically, analyzed accurately, and maintained for regulatory compliance.

2. Scope

This SOP applies to all personnel in the Quality Control (QC), Quality Assurance (QA), and Research & Development (R&D) departments responsible for recording, reviewing, and maintaining stability study results.

3. Responsibilities

  • QC Analyst: Records stability test results at defined intervals.
  • QC Supervisor: Reviews data accuracy and ensures compliance with study protocols.
  • QA Officer: Verifies the completeness and correctness of stability documentation.
  • R&D Scientist: Analyzes data trends and provides recommendations if necessary.
  • QA Manager: Approves final documentation and ensures compliance with regulatory guidelines.

4. Accountability

The QA and QC Managers are accountable for ensuring stability study documentation aligns with ICH Q1A(R2) guidelines.

5. Procedure

5.1 Data Recording Requirements

  • Ensure that all stability study results are documented in a pre-approved format.
  • Each data entry must include:
    • Batch number
    • Storage condition
    • Testing interval
    • Parameter tested
    • Result obtained
    • Name and signature of the analyst

5.2 Stability Data Analysis

  • Analyze stability data
for trends and significant variations.
  • Compare results against predefined acceptance criteria.
  • Document any deviations and initiate Out-of-Specification (OOS) procedures if necessary.
  • 5.3 Review and Approval Process

    • QC Supervisor reviews raw data for accuracy and completeness.
    • QA Officer verifies results and ensures data integrity.
    • Final approval of the stability study report by the QA Manager.

    5.4 Handling Deviations and Out-of-Specification (OOS) Results

    • Document deviations and OOS findings in the Stability Deviation Log.
    • Investigate and identify the root cause of any stability failures.
    • Implement corrective and preventive actions (CAPA) if necessary.

    5.5 Storage and Retention of Stability Study Data

    • Store stability records in a secure, controlled-access location.
    • Ensure compliance with regulatory record retention policies (e.g., minimum 5 years after product expiry).
    • Maintain electronic backups for long-term storage.

    6. Abbreviations

    • GMP – Good Manufacturing Practices
    • QA – Quality Assurance
    • QC – Quality Control
    • ICH – International Council for Harmonisation
    • OOS – Out-of-Specification
    • CAPA – Corrective and Preventive Action

    7. Documents

    • Stability Study Result Log (Annexure-1)
    • Final Stability Study Report (Annexure-2)

    8. References

    • ICH Q1A(R2) Stability Testing of New Drug Substances and Products
    • WHO GMP Guidelines for Pharmaceutical Stability Studies

    9. SOP Version

    Version 2.0

    10. Approval Section

    Prepared By Checked By Approved By
    Signature
    Date
    Name
    Designation
    Department

    11. Annexures

    Annexure-1: Stability Study Result Log

    Date Batch Number Storage Condition Testing Interval Parameter Tested Result Reviewed By
    01/02/2025 OINT-701 25°C/60% RH 6 Months Viscosity Compliant QA Officer
    01/08/2025 OINT-701 25°C/60% RH 12 Months pH Stable QA Officer

    Annexure-2: Final Stability Study Report

    Batch Number Study Start Date Study End Date Test Parameters Results Final Conclusion
    OINT-701 01/02/2025 01/02/2028 pH, Viscosity, Microbial Limits Compliant Meets Stability Criteria
    OINT-702 01/03/2025 01/03/2028 Appearance, Assay, Microbial Limits Compliant Meets Stability Criteria

    12. Revision History:

    Revision Date Revision No. Details of Revision Reason for Revision Approved By
    01/01/2024 1.0 Initial Version New SOP QA Head
    01/02/2025 2.0 Updated SOP Format Standardization of Document QA Head
    Exit mobile version